Molecular targeting drugs for treatment of lung cancer patientsPrevention of adverse skin reactions and their care

SelectEarSt2014year42015year4month period medicalHouseadmissionof lung cancerexample,tohavesufferfrom all accept molecular sacrificial drugsobjectsgoverningtherapy,by different caremethod divides patients into study Group and control Group,30-if•;where control group patients give to routine care apply,Research group Patients on the Tand on the basis of new Zealand treatment to to targeted care interventions shi,Compare two groups of patients after treatment caused by skin not good rate of occurrence,•knot Fruit:Study Group patients Elevel skin Adverse reactions send Live rate to 13.33%significantly below to Indra,King and to 30.00%;Elevela sentence The incidence of inflammationto3.%Beansbelowcontrol group26.67% (p< 0.05)powerknottheory:SubsubearlyAdverse skin reactions to patients with lung cancer treated with drugs,should take targeted prevention and care measuresapply,Reduce skin undesirablereaction to occurstroke,relieve patient pain,improve compliance with treatmentsex,branchgood match againstmonthmediumpainruleTherapy,improve the quality of volunteersQuantityF